The impact of fear of cancer recurrence on healthcare utilization among long-term breast cancer survivors recruited through ECOG-ACRIN trials

dc.contributor.authorVachon, Eric
dc.contributor.authorKrueger, Ellen
dc.contributor.authorChampion, Victoria L.
dc.contributor.authorHaggstrom, David A.
dc.contributor.authorCella, David
dc.contributor.authorCohee, Andrea A.
dc.date.accessioned2021-10-04T21:18:51Z
dc.date.available2021-10-04T21:18:51Z
dc.date.issued2021
dc.description.abstractObjective To examine the relationship between fear of cancer recurrence (FCR) and healthcare utilization among long-term breast cancer survivors (BCS). Methods In a cross-sectional survey study, 505 younger survivors (YS: ≤45 years) and 622 older survivors (OS: 55–70 years) 3–8 years from diagnosis completed a questionnaire assessing demographics, medical history, FCR, and healthcare utilization. Healthcare utilization consisted of breast cancer (BC) and non-BC-related routine and nonroutine utilization. Results YS had significantly higher FCR than OS (p < 0.01). Independent of age, FCR was significantly associated with all three types of BC-related utilization (p < 0.05). In the multivariate models, we found a significant, positive interaction effect between FCR and increased comorbidities on nonroutine BC appointments (p = 0.01) and BC-related emergency room visits (p = 0.03). Additionally, comorbidities were associated with non-BC-related utilization (p < 0.01), and nonwhites were more likely to utilize nonroutine resources, both BC and non-BC-related (p < 0.01). Conclusions Increased FCR has been associated with hypervigilance among survivors and may lead to increased healthcare utilization. YS are at higher risk for increased FCR and psychosocial concerns, which may lead to overutilization. Providers should be aware that higher FCR may be related to increased use of healthcare resources and that these patients might be better served with supportive resources to increase quality of life and decrease inappropriate utilization. While this study provides increased evidence of the relationship between FCR and healthcare utilization, interventions are needed for survivors at risk to address unmet needs, especially as life expectancy increases among BCS.en_US
dc.identifier.citationVachon, E., Krueger, E., Champion, V. L., Haggstrom, D. A., Cella, D., & Cohee, A. A. (2021). The impact of fear of cancer recurrence on healthcare utilization among long‐term breast cancer survivors recruited through ECOG‐ACRIN trials. Psycho‐Oncology, 30(3), 279-286.en_US
dc.identifier.urihttps://hdl.handle.net/1805/26692
dc.language.isoen_USen_US
dc.publisherWileyen_US
dc.relation.isversionof10.1002/pon.5568en_US
dc.subjectBreast canceren_US
dc.subjectCanceren_US
dc.subjectFear of cancer recurrenceen_US
dc.subjectHealthcare utilizationen_US
dc.subjectLong-term breast cancer survivorsen_US
dc.subjectOncologyen_US
dc.subjectPsycho-oncologyen_US
dc.titleThe impact of fear of cancer recurrence on healthcare utilization among long-term breast cancer survivors recruited through ECOG-ACRIN trialsen_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Vachon2021Impact-AAM.pdf
Size:
332.88 KB
Format:
Adobe Portable Document Format
Description:
Article
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.99 KB
Format:
Item-specific license agreed upon to submission
Description: